Literature DB >> 17608781

Genome scanning tests for comparing amino acid sequences between groups.

Peter B Gilbert1, Chunyuan Wu, David V Jobes.   

Abstract

Consider a placebo-controlled preventive HIV vaccine efficacy trial. An HIV amino acid sequence is measured from each volunteer who acquires HIV, and these sequences are aligned together with the reference HIV sequence represented in the vaccine. We develop genome scanning methods to identify positions at which the amino acids in infected vaccine recipient sequences either (A) are more divergent from the reference amino acid than the amino acids in infected placebo recipient sequences or (B) have a different frequency distribution than the placebo sequences, irrespective of a reference amino acid. We consider t-test-type statistics for problem A and Euclidean, Mahalanobis, and Kullback-Leibler-type statistics for problem B. The test statistics incorporate weights to reflect biological information contained in different amino acid positions and mismatches. Position-specific p-values are obtained by approximating the null distribution of the statistics either by a permutation procedure or by a nonparametric estimation. A permutation method is used to estimate a cut-off p-value to control the per comparison error rate at a prespecified level. The methods are examined in simulations and are applied to two HIV examples. The methods for problem B address the general problem of comparing discrete frequency distributions between groups in a high-dimensional data setting.

Mesh:

Substances:

Year:  2007        PMID: 17608781     DOI: 10.1111/j.1541-0420.2007.00845.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.

Authors:  Morgane Rolland; Siriphan Manocheewa; J Victor Swain; Erinn C Lanxon-Cookson; Moon Kim; Dylan H Westfall; Brendan B Larsen; Peter B Gilbert; James I Mullins
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 2.  Complex immune correlates of protection in HIV-1 vaccine efficacy trials.

Authors:  Georgia D Tomaras; Stanley A Plotkin
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

3.  Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.

Authors:  Fang-Hua Lee; Rosemarie Mason; Hugh Welles; Gerald H Learn; Brandon F Keele; Mario Roederer; Katharine J Bar
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

4.  RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection.

Authors:  Eric Lewitus; Eric Sanders-Buell; Meera Bose; Anne Marie O'Sullivan; Kultida Poltavee; Yifan Li; Hongjun Bai; Thembi Mdluli; Gina Donofrio; Bonnie Slike; Hong Zhao; Kim Wong; Lennie Chen; Shana Miller; Jenica Lee; Bahar Ahani; Steven Lepore; Sevan Muhammad; Rebecca Grande; Ursula Tran; Vincent Dussupt; Letzibeth Mendez-Rivera; Sorachai Nitayaphan; Jaranit Kaewkungwal; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Robert J O'Connell; Holly Janes; Peter B Gilbert; Robert Gramzinski; Sandhya Vasan; Merlin L Robb; Nelson L Michael; Shelly J Krebs; Joshua T Herbeck; Paul T Edlefsen; James I Mullins; Jerome H Kim; Sodsai Tovanabutra; Morgane Rolland
Journal:  Virus Evol       Date:  2021-07-09

5.  A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.

Authors:  T Hertz; M G Logan; M Rolland; C A Magaret; C Rademeyer; A Fiore-Gartland; P T Edlefsen; A DeCamp; H Ahmed; N Ngandu; B B Larsen; N Frahm; J Marais; R Thebus; D Geraghty; J Hural; L Corey; J Kublin; G Gray; M J McElrath; J I Mullins; P B Gilbert; C Williamson
Journal:  Vaccine       Date:  2016-10-15       Impact factor: 3.641

6.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Allan C deCamp; Nicole Frahm; Peter B Gilbert; Eric Sanders-Buell; Laura Heath; Craig A Magaret; Meera Bose; Andrea Bradfield; Annemarie O'Sullivan; Jacqueline Crossler; Teresa Jones; Marty Nau; Kim Wong; Hong Zhao; Dana N Raugi; Stephanie Sorensen; Julia N Stoddard; Brandon S Maust; Wenjie Deng; John Hural; Sheri Dubey; Nelson L Michael; John Shiver; Lawrence Corey; Fusheng Li; Steve G Self; Jerome Kim; Susan Buchbinder; Danilo R Casimiro; Michael N Robertson; Ann Duerr; M Juliana McElrath; Francine E McCutchan; James I Mullins
Journal:  Nat Med       Date:  2011-02-27       Impact factor: 53.440

7.  Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections.

Authors:  S Gnanakaran; Tanmoy Bhattacharya; Marcus Daniels; Brandon F Keele; Peter T Hraber; Alan S Lapedes; Tongye Shen; Brian Gaschen; Mohan Krishnamoorthy; Hui Li; Julie M Decker; Jesus F Salazar-Gonzalez; Shuyi Wang; Chunlai Jiang; Feng Gao; Ronald Swanstrom; Jeffrey A Anderson; Li-Hua Ping; Myron S Cohen; Martin Markowitz; Paul A Goepfert; Michael S Saag; Joseph J Eron; Charles B Hicks; William A Blattner; Georgia D Tomaras; Mohammed Asmal; Norman L Letvin; Peter B Gilbert; Allan C Decamp; Craig A Magaret; William R Schief; Yih-En Andrew Ban; Ming Zhang; Kelly A Soderberg; Joseph G Sodroski; Barton F Haynes; George M Shaw; Beatrice H Hahn; Bette Korber
Journal:  PLoS Pathog       Date:  2011-09-29       Impact factor: 6.823

8.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Authors:  Morgane Rolland; Paul T Edlefsen; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Tomer Hertz; Allan C deCamp; Chris Carrico; Sergey Menis; Craig A Magaret; Hasan Ahmed; Michal Juraska; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; Jason S McLellan; Ivelin Georgiev; Peter D Kwong; Jonathan M Carlson; Nelson L Michael; William R Schief; Peter B Gilbert; James I Mullins; Jerome H Kim
Journal:  Nature       Date:  2012-09-10       Impact factor: 49.962

9.  Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.

Authors:  Georgia D Tomaras; Barton F Haynes
Journal:  Vaccines (Basel)       Date:  2014-03

10.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.

Authors:  Paul T Edlefsen; Morgane Rolland; Tomer Hertz; Sodsai Tovanabutra; Andrew J Gartland; Allan C deCamp; Craig A Magaret; Hasan Ahmed; Raphael Gottardo; Michal Juraska; Connor McCoy; Brendan B Larsen; Eric Sanders-Buell; Chris Carrico; Sergey Menis; Gustavo H Kijak; Meera Bose; Miguel A Arroyo; Robert J O'Connell; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Supachai Rerks-Ngarm; Merlin L Robb; Tatsiana Kirys; Ivelin S Georgiev; Peter D Kwong; Konrad Scheffler; Sergei L Kosakovsky Pond; Jonathan M Carlson; Nelson L Michael; William R Schief; James I Mullins; Jerome H Kim; Peter B Gilbert
Journal:  PLoS Comput Biol       Date:  2015-02-03       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.